Efficacy and Safety of Empagliflozin (BI 10773) in Patients With Type 2 Diabetes and Renal Impairment

PHASE3CompletedINTERVENTIONAL
Enrollment

741

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Diabetes Mellitus, Type 2Renal Insufficiency
Interventions
DRUG

BI 10773

BI 10773 tablets once daily

DRUG

Placebo

Placebo tablets identical to BI 10773 low dose

DRUG

Placebo

Placebo tablets identical to BI 10773 high dose

DRUG

BI 10773

BI 10773 tablets once daily

DRUG

Placebo

Placebo tablets identical to BI 10773 low dose

DRUG

Placebo

Placebo tablets identical to BI 10773 high dose

Trial Locations (127)

Unknown

1245.36.10014 Boehringer Ingelheim Investigational Site, Anaheim

1245.36.10019 Boehringer Ingelheim Investigational Site, Lomita

1245.36.10017 Boehringer Ingelheim Investigational Site, Plantation

1245.36.10009 Boehringer Ingelheim Investigational Site, West Palm Beach

1245.36.10018 Boehringer Ingelheim Investigational Site, Honolulu

1245.36.10015 Boehringer Ingelheim Investigational Site, Shreveport

1245.36.10021 Boehringer Ingelheim Investigational Site, Endwell

1245.36.10008 Boehringer Ingelheim Investigational Site, Greenville

1245.36.10005 Boehringer Ingelheim Investigational Site, Bethlehem

1245.36.10003 Boehringer Ingelheim Investigational Site, Melrose Park

1245.36.10004 Boehringer Ingelheim Investigational Site, Greer

1245.36.10012 Boehringer Ingelheim Investigational Site, Corpus Christi

1245.36.10013 Boehringer Ingelheim Investigational Site, Dallas

1245.36.10002 Boehringer Ingelheim Investigational Site, Houston

1245.36.10007 Boehringer Ingelheim Investigational Site, San Antonio

1245.36.10023 Boehringer Ingelheim Investigational Site, Renton

1245.36.10011 Boehringer Ingelheim Investigational Site, Spokane

1245.36.10006 Boehringer Ingelheim Investigational Site, Tacoma

1245.36.20052 Boehringer Ingelheim Investigational Site, Calgary

1245.36.20054 Boehringer Ingelheim Investigational Site, Calgary

1245.36.20023 Boehringer Ingelheim Investigational Site, Edmonton

1245.36.20055 Boehringer Ingelheim Investigational Site, Edmonton

1245.36.20048 Boehringer Ingelheim Investigational Site, Winnipeg

1245.36.20051 Boehringer Ingelheim Investigational Site, Mississauga

1245.36.20086 Boehringer Ingelheim Investigational Site, Thornhill

1245.36.20053 Boehringer Ingelheim Investigational Site, Toronto

1245.36.20056 Boehringer Ingelheim Investigational Site, Montreal

1245.36.33001 Boehringer Ingelheim Investigational Site, Corbeil-Essonnes

1245.36.33042 Boehringer Ingelheim Investigational Site, Nanterre

1245.36.33041 Boehringer Ingelheim Investigational Site, Nice

1245.36.33036 Boehringer Ingelheim Investigational Site, Paris

1245.36.33040 Boehringer Ingelheim Investigational Site, Poitiers

1245.36.33037 Boehringer Ingelheim Investigational Site, Reims

1245.36.33038 Boehringer Ingelheim Investigational Site, Reims

1245.36.33043 Boehringer Ingelheim Investigational Site, Rennes

1245.36.33044 Boehringer Ingelheim Investigational Site, Saint-Mandé

1245.36.85201 Boehringer Ingelheim Investigational Site, Hong Kong

1245.36.85204 Boehringer Ingelheim Investigational Site, Hong Kong

1245.36.85205 Boehringer Ingelheim Investigational Site, Hong Kong

1245.36.85206 Boehringer Ingelheim Investigational Site, Hong Kong

1245.36.85202 Boehringer Ingelheim Investigational Site, Kowloon

1245.36.91209 Boehringer Ingelheim Investigational Site, Aligarh, Uttar Pradesh

1245.36.91202 Boehringer Ingelheim Investigational Site, Bangalore

1245.36.91204 Boehringer Ingelheim Investigational Site, Bangalore

1245.36.91205 Boehringer Ingelheim Investigational Site, Bangalore

1245.36.91208 Boehringer Ingelheim Investigational Site, Bangalore

1245.36.91201 Boehringer Ingelheim Investigational Site, Chennai

1245.36.91214 Boehringer Ingelheim Investigational Site, Chennai

1245.36.91213 Boehringer Ingelheim Investigational Site, Gūrgaon

1245.36.91203 Boehringer Ingelheim Investigational Site, Hyderabad

1245.36.91211 Boehringer Ingelheim Investigational Site, Kolkata

1245.36.91210 Boehringer Ingelheim Investigational Site, Mangalore

1245.36.91215 Boehringer Ingelheim Investigational Site, Mumbai, Maharastra

1245.36.91216 Boehringer Ingelheim Investigational Site, Nashik

1245.36.91212 Boehringer Ingelheim Investigational Site, New Delhi

1245.36.91207 Boehringer Ingelheim Investigational Site, Pune

1245.36.60003 Boehringer Ingelheim Investigational Site, Johor Baru

1245.36.60006 Boehringer Ingelheim Investigational Site, Kelantan Kota Bahru

1245.36.60005 Boehringer Ingelheim Investigational Site, Kuala Lumpur

1245.36.60009 Boehringer Ingelheim Investigational Site, Kuala Lumpur

1245.36.60004 Boehringer Ingelheim Investigational Site, Kuala Pahang

1245.36.60007 Boehringer Ingelheim Investigational Site, Perak

1245.36.60011 Boehringer Ingelheim Investigational Site, Perak

1245.36.60010 Boehringer Ingelheim Investigational Site, Pulau Piang

1245.36.60008 Boehringer Ingelheim Investigational Site, Sabak Bernam

1245.36.60001 Boehringer Ingelheim Investigational Site, Selangor Darul Ehsan

1245.36.31015 Boehringer Ingelheim Investigational Site, Amersfoort

1245.36.31012 Boehringer Ingelheim Investigational Site, Geleen

1245.36.31017 Boehringer Ingelheim Investigational Site, Hardenberg

1245.36.31009 Boehringer Ingelheim Investigational Site, Maastricht

1245.36.31004 Boehringer Ingelheim Investigational Site, The Hague

1245.36.31002 Boehringer Ingelheim Investigational Site, Utrecht

1245.36.31003 Boehringer Ingelheim Investigational Site, Zaandam

1245.36.63008 Boehringer Ingelheim Investigational Site, Cavite City

1245.36.63006 Boehringer Ingelheim Investigational Site, Cebu

1245.36.63005 Boehringer Ingelheim Investigational Site, Manila

1245.36.63007 Boehringer Ingelheim Investigational Site, Manila

1245.36.63009 Boehringer Ingelheim Investigational Site, Marikina City

1245.36.63010 Boehringer Ingelheim Investigational Site, Tacloban City

1245.36.48006 Boehringer Ingelheim Investigational Site, Gdansk

1245.36.48003 Boehringer Ingelheim Investigational Site, Lodz

1245.36.48004 Boehringer Ingelheim Investigational Site, Lodz

1245.36.48001 Boehringer Ingelheim Investigational Site, Lublin

1245.36.48002 Boehringer Ingelheim Investigational Site, Poznan

1245.36.48007 Boehringer Ingelheim Investigational Site, Ruda Śląska

1245.36.48005 Boehringer Ingelheim Investigational Site, Torun

1245.36.35003 Boehringer Ingelheim Investigational Site, Faro

1245.36.35002 Boehringer Ingelheim Investigational Site, Lisbon

1245.36.35004 Boehringer Ingelheim Investigational Site, Lisbon

1245.36.35001 Boehringer Ingelheim Investigational Site, Vila Nova de Gaia

1245.36.70008 Boehringer Ingelheim Investigational Site, Moscow

1245.36.70009 Boehringer Ingelheim Investigational Site, Moscow

1245.36.70011 Boehringer Ingelheim Investigational Site, Moscow

1245.36.70004 Boehringer Ingelheim Investigational Site, Saint Petersburg

1245.36.70006 Boehringer Ingelheim Investigational Site, Saint Petersburg

1245.36.70002 Boehringer Ingelheim Investigational Site, Vsevolozhsk

1245.36.74011 Boehringer Ingelheim Investigational Site, Moldava nad Bodvou

1245.36.74013 Boehringer Ingelheim Investigational Site, Nitra

1245.36.74008 Boehringer Ingelheim Investigational Site, Nové Mesto nad Váhom

1245.36.74012 Boehringer Ingelheim Investigational Site, Prešov

1245.36.74007 Boehringer Ingelheim Investigational Site, Trenčín

1245.36.74009 Boehringer Ingelheim Investigational Site, Žilina

1245.36.76021 Boehringer Ingelheim Investigational Site, Plumstead

1245.36.76020 Boehringer Ingelheim Investigational Site, Somerset West

1245.36.76022 Boehringer Ingelheim Investigational Site, Somerset West

1245.36.34015 Boehringer Ingelheim Investigational Site, Barcelona

1245.36.34009 Boehringer Ingelheim Investigational Site, Granada

1245.36.34014 Boehringer Ingelheim Investigational Site, L'Hospitalet de Llobregat

1245.36.34012 Boehringer Ingelheim Investigational Site, Madrid

1245.36.34013 Boehringer Ingelheim Investigational Site, Madrid

1245.36.34020 Boehringer Ingelheim Investigational Site, Manresa

1245.36.34021 Boehringer Ingelheim Investigational Site, San Sebastián de los Reyes

1245.36.34016 Boehringer Ingelheim Investigational Site, Santiago de Compostela

1245.36.34017 Boehringer Ingelheim Investigational Site, Valencia

1245.36.34019 Boehringer Ingelheim Investigational Site, Valencia

1245.36.44018 Boehringer Ingelheim Investigational Site, Bath

1245.36.44010 Boehringer Ingelheim Investigational Site, Birmingham

1245.36.44013 Boehringer Ingelheim Investigational Site, Blackpool

1245.36.44016 Boehringer Ingelheim Investigational Site, Blackpool

1245.36.44026 Boehringer Ingelheim Investigational Site, Chester

1245.36.44012 Boehringer Ingelheim Investigational Site, Chesterfield

1245.36.44025 Boehringer Ingelheim Investigational Site, Doncaster

1245.36.44036 Boehringer Ingelheim Investigational Site, Epsom

1245.36.44001 Boehringer Ingelheim Investigational Site, Frome

1245.36.44007 Boehringer Ingelheim Investigational Site, Midsomer Norton

1245.36.44023 Boehringer Ingelheim Investigational Site, Nantwich

1245.36.44024 Boehringer Ingelheim Investigational Site, Welwyn Garden City

Sponsors
All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

Boehringer Ingelheim

INDUSTRY